Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328

Q3 FY23 results · Oct–Dec 2022

Krsnaa Diagnostics reported revenue from operations of ₹118.10 crore (up 10.9% from Q3 FY22) and net profit of ₹13.64 crore (down 16.5% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations118.10106.47+10.9%122.94−3.9%
Other income4.544.34+4.7%4.27+6.4%
Total income122.64110.81+10.7%127.21−3.6%
Profit before tax17.7821.35−16.7%20.16−11.8%
Net profit for the period13.6416.33−16.5%15.34−11.0%
EPS, basic (₹)4.355.67−23.3%5.73−24.1%
Net margin (%)11.615.312.5
Standalone · ₹ crore
ItemQ3 FY23Q3 FY22YoYQ2 FY23QoQ
Revenue from operations115.74106.31+8.9%120.72−4.1%
Other income4.554.34+4.9%4.27+6.5%
Total income120.29110.65+8.7%124.99−3.8%
Profit before tax22.1722.25−0.4%23.69−6.4%
Net profit for the period16.8617.23−2.1%17.97−6.2%
EPS, basic (₹)5.375.97−10.1%5.73−6.3%
Net margin (%)14.616.214.9
Consolidated
Filed with BSE
16 Feb 2023, 16:31 IST
Board meeting
13 Feb 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
16 Feb 2023, 16:31 IST
Board meeting
13 Feb 2023
Period
01 Oct 2022 to 31 Dec 2022
Review status
Unaudited
Source
XBRL filing on BSE